STOCK COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement [Abstract]

Share-based Payment Arrangement, Cost by Plan

The amounts of stock compensation expense recorded in the Company’s Consolidated Statements of Operations for the years ended December 31, 2021, 2020 and 2019 were as follows:

	Year Ended December 31,
(in millions)	2021		2020		2019
Cost of products sold	$	3	$	1	$	2
Selling, general, and administrative expense	44		44		61
Research and development expense	2		1		2
Total stock based compensation expense	$	49	$	46	$	65
Related deferred income tax benefit	$	6	$	5	$	8

Schedule of Assumptions Used to Determine Compensation Cost for the Company's Non-qualified Stock Options Issued

The Company uses the Black-Scholes option-pricing model to estimate the fair value of each option awarded. The average assumptions used to determine compensation cost for the Company’s NQSOs issued were as follows:

	Year Ended December 31,
	2021			2020			2019
Weighted average fair value per share	$	15.90		$	10.03		$	12.20
Expected dividend yield	0.68		%	0.84		%	0.71		%
Risk-free interest rate	0.79		%	0.77		%	2.36		%
Expected volatility	31.5		%	24.0		%	22.6		%
Expected life (years)	5.08			5.49			6.00

Schedule of Non-qualified Stock Option Transactions

The NQSO transactions for the year ended December 31, 2021 were as follows:

	Outstanding					Exercisable
(in millions, except per share amounts)	Shares	Weighted Average Exercise Price		Aggregate Intrinsic Value		Shares	Weighted Average Exercise Price		Aggregate Intrinsic Value
December 31, 2020	4.0	$	50.01	$	17	2.7	$	50.28	$	12
Granted	0.5	58.85
Exercised	(1.1)	46.81
Forfeited	(0.2)	53.03
December 31, 2021	3.2	$	52.44	$	15	2.2	$	52.05	$	11

Schedule of Information about Non-qualified Stock Options Outstanding

Information about NQSOs outstanding for the year ended December 31, 2021 were as follows:

			Outstanding				Exercisable
			Number Outstanding at December 31, 2021	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number Exercisable at December 31, 2021	Weighted Average Exercise Price
Range of Exercise Prices
(in millions, except per share amounts and life)
30.01	-	40.00	0.1	1.4	$	37.29	0.1	$	37.29
40.01	-	50.00	1.4	5.9	47.31		0.8	46.73
50.01	-	60.00	1.4	6.0	56.32		0.9	55.05
60.01	-	70.00	0.3	4.3	62.37		0.4	62.24
			3.2				2.2

Schedule of the Unvested RSU Transactions

The unvested RSU transactions for the year ended December 31, 2021 were as follows:

	Unvested Restricted Stock Units
	Shares	Weighted Average Grant Date Fair Value
(in millions, except per share amounts)
Unvested at December 31, 2020	4.2	$	47.29
Granted	1.0	63.61
Vested	(1.5)	45.08
Forfeited	(0.6)	50.01
Unvested at December 31, 2021	3.1	$	53.52